Molecular Transducers of Physical Activity Consortium (MoTrPAC): human studies design and protocol
- PMID: 38634503
- PMCID: PMC11427038
- DOI: 10.1152/japplphysiol.00102.2024
Molecular Transducers of Physical Activity Consortium (MoTrPAC): human studies design and protocol
Abstract
Physical activity, including structured exercise, is associated with favorable health-related chronic disease outcomes. Although there is evidence of various molecular pathways that affect these responses, a comprehensive molecular map of these molecular responses to exercise has not been developed. The Molecular Transducers of Physical Activity Consortium (MoTrPAC) is a multicenter study designed to isolate the effects of structured exercise training on the molecular mechanisms underlying the health benefits of exercise and physical activity. MoTrPAC contains both a preclinical and human component. The details of the human studies component of MoTrPAC that include the design and methods are presented here. The human studies contain both an adult and pediatric component. In the adult component, sedentary participants are randomized to 12 wk of Control, Endurance Exercise Training, or Resistance Exercise Training with outcomes measures completed before and following the 12 wk. The adult component also includes recruitment of highly active endurance-trained or resistance-trained participants who only complete measures once. A similar design is used for the pediatric component; however, only endurance exercise is examined. Phenotyping measures include weight, body composition, vital signs, cardiorespiratory fitness, muscular strength, physical activity and diet, and other questionnaires. Participants also complete an acute rest period (adults only) or exercise session (adults, pediatrics) with collection of biospecimens (blood only for pediatrics) to allow for examination of the molecular responses. The design and methods of MoTrPAC may inform other studies. Moreover, MoTrPAC will provide a repository of data that can be used broadly across the scientific community.NEW & NOTEWORTHY The Molecular Transducers of Physical Activity Consortium (MoTrPAC) will be the first large trial to isolate the effects of structured exercise training on the molecular mechanisms underlying the health benefits of exercise and physical activity. By generating a compendium of the molecular responses to exercise, MoTrPAC will lay the foundation for a new era of biomedical research on Precision Exercise Medicine. Presented here is the design, protocols, and procedures for the MoTrPAC human studies.
Keywords: adipose tissue; biospecimens; molecular transducers; physical activity; skeletal muscle.
Conflict of interest statement
Dr. J. M. Jakicic is a member of the Scientific Advisory Board for Wondr Health, Inc. None of the other authors has any conflicts of interest, financial or otherwise, to disclose.
Figures







References
-
- US Department of Health and Human Services. Physical Activity Guidelines Advisory Committee Report 2008 US Department of Health and Human Services (Online). http://www.health.gov/paguidelines/committeereport.aspx [2009 Jan 19].
-
- US Department of Health and Human Services. 2008 Physical Activity Guidelines for Americans. Washington, DC: Department of Health and Human Services, 2008.
-
- US Department of Health and Human Services. Physical Activity Guidelines Advisory Committee Report 2018. Washington, DC: US Department of Health and Human Services, 2018.
Publication types
MeSH terms
Grants and funding
- P30 ES025128/ES/NIEHS NIH HHS/United States
- U24DK112341/HHS | National Institutes of Health (NIH)
- U01 AG055135/AG/NIA NIH HHS/United States
- U01 AR071158/AR/NIAMS NIH HHS/United States
- U01 AR071130/AR/NIAMS NIH HHS/United States
- U24DK112326/HHS | National Institutes of Health (NIH)
- U01 AR071124/AR/NIAMS NIH HHS/United States
- U24 DK112341/DK/NIDDK NIH HHS/United States
- U01AR071160/HHS | National Institutes of Health (NIH)
- U24OD026629/HHS | National Institutes of Health (NIH)
- P20 GM144269/GM/NIGMS NIH HHS/United States
- U24 DK112326/DK/NIDDK NIH HHS/United States
- U24 OD026629/OD/NIH HHS/United States
- U24 DK112331/DK/NIDDK NIH HHS/United States
- U24DK112340/HHS | National Institutes of Health (NIH)
- U24 AR071113/AR/NIAMS NIH HHS/United States
- U01 AR071160/AR/NIAMS NIH HHS/United States
- U24 DK112348/DK/NIDDK NIH HHS/United States
- U01AR071130/HHS | National Institutes of Health (NIH)
- P30 DK040561/DK/NIDDK NIH HHS/United States
- U01AG055135/HHS | National Institutes of Health (NIH)
- U01AR071133/HHS | National Institutes of Health (NIH)
- U24DK112348/HHS | National Institutes of Health (NIH)
- U01 AG055137/AG/NIA NIH HHS/United States
- U24 OD036598/OD/NIH HHS/United States
- U01 AG055133/AG/NIA NIH HHS/United States
- U01 AR071128/AR/NIAMS NIH HHS/United States
- U01 AR071133/AR/NIAMS NIH HHS/United States
- U01AR071128/HHS | National Institutes of Health (NIH)
- U24 DK112340/DK/NIDDK NIH HHS/United States
- U24DK112342/HHS | National Institutes of Health (NIH)
- P30 AG028740/AG/NIA NIH HHS/United States
- U01AG055137/HHS | National Institutes of Health (NIH)
- U01AR071124/HHS | National Institutes of Health (NIH)
- U24 EB023674/EB/NIBIB NIH HHS/United States
- U24AR071113/HHS | National Institutes of Health (NIH)
- U24DK112331/HHS | National Institutes of Health (NIH)
- U24DK112349/HHS | National Institutes of Health (NIH)
- P30 AG044271/AG/NIA NIH HHS/United States
- U01AG055133/HHS | National Institutes of Health (NIH)
- U01AR071158/HHS | National Institutes of Health (NIH)
- U24 DK112349/DK/NIDDK NIH HHS/United States
- U01 AR071150/AR/NIAMS NIH HHS/United States
- U24 DK112342/DK/NIDDK NIH HHS/United States
- U01AR071150/HHS | National Institutes of Health (NIH)